Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:872193.
doi: 10.1155/2015/872193. Epub 2015 Mar 19.

Soluble α -Klotho Serum Levels in Chronic Kidney Disease

Affiliations

Soluble α -Klotho Serum Levels in Chronic Kidney Disease

Silverio Rotondi et al. Int J Endocrinol. 2015.

Abstract

Transmembrane α-Klotho (TM-Klotho), expressed in renal tubules, is a cofactor for FGF23-receptor. Circulating soluble-α-Klotho (s-Klotho) results from TM-Klotho shedding and acts on Phosphate (P) and Calcium (Ca) tubular transport. Decreased TM-Klotho, described in experimental chronic kidney disease (CKD), prevents actions of FGF23 and lessens circulating s-Klotho. Thus, levels of s-Klotho could represent a marker of CKD-MBD. To evaluate the clinical significance of s-Klotho in CKD we assayed serum s-Klotho and serum FGF23 in 68 patients (age 58 ± 15; eGFR 45 ± 21 mL/min). s-Klotho was lower than normal (519 ± 183 versus 845 ± 330 pg/mL, P < .0001) in renal patients and its reduction was detectable since CKD stage 2 (P < .01). s-Klotho correlated positively with eGFR and serum calcium (Cas) and negatively with serum phosphate (Ps), PTH and FGF23. FGF23 was higher than normal (73 ± 51 versus 36 ± 11, P < .0002) with significantly increased levels since CKD stage 2 (P < .001). Our data indicate a negative effect of renal disease on circulating s-Klotho starting very early in CKD. Assuming that s-Klotho mirrors TM-Klotho synthesis, low circulating s-Klotho seems to reflect the ensuing of tubular resistance to FGF23, which, accordingly, is increased. We endorse s-Klotho as an early marker of CKD-MBD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation test of s-Klotho levels with FGF23 levels in CKD.
Figure 2
Figure 2
Correlation tests of eGFR with s-Klotho levels (a) and FGF23 (b).
Figure 3
Figure 3
s-Klotho (soluble Klotho) (a) and FGF23 (fibroblast growth factor 23) and (b) serum levels stratified by CKD stage and compared with reference values. Indicated are medians, first and third quartiles, minimal and maximal values. Values between 1.5 and 3 times IQR above the third quartile or below the first are represented by circles. Wilcoxon rank-sum tests. KDOQI: National Kidney Foundation Disease Outcomes Quality Initiative clinical practice guidelines [15]. # P < .01 versus reference value; * P < .001 versus reference value; § P < .002 versus reference value.
Figure 4
Figure 4
Correlation tests of s-Klotho levels with: (a) PTH, (b) Ps, (c) Cas.
Figure 5
Figure 5
Correlation tests of FGF23 with: (a) PTH, (b) Ps, (c) 1,25D, (d) FEPO4.

References

    1. Mian I. S. Sequence, structural, functional, and phylogenetic analyses of three glycosidase families. Blood Cells, Molecules and Diseases. 1998;24(2):83–100. doi: 10.1006/bcmd.1998.9998. - DOI - PubMed
    1. Kurosu H., Ogawa Y., Miyoshi M., et al. Regulation of fibroblast growth factor-23 signaling by Klotho. The Journal of Biological Chemistry. 2006;281(10):6120–6123. doi: 10.1074/jbc.C500457200. - DOI - PMC - PubMed
    1. Urakawa I., Yamazaki Y., Shimada T., et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006;444(7120):770–774. doi: 10.1038/nature05315. - DOI - PubMed
    1. Liu S., Tang W., Zhou J., et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. Journal of the American Society of Nephrology. 2006;17(5):1305–1315. doi: 10.1681/ASN.2005111185. - DOI - PubMed
    1. Chen C.-D., Podvin S., Gillespie E., Leeman S. E., Abraham C. R. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(50):19796–19801. doi: 10.1073/pnas.0709805104. - DOI - PMC - PubMed